Table 1 Correlation between METTL14 expression and different clinical characteristics.
Characteristics | n = 136 | METTL14 expression | P value | |
|---|---|---|---|---|
high(%)(n = 68) | low(%)(n = 68) | |||
Gender | Â | Â | Â | 0.727 |
 Male | 81 (59.6%) | 39 (57.4%) | 42 (61.8%) | |
 Female | 55 (40.4%) | 29 (42.6%) | 26 (38.2%) | |
Age (years) | Â | Â | Â | 0.716 |
  < 60 | 45 (33.1%) | 24 (35.3%) | 21 (30.9%) | |
  ≥ 60 | 91 (66.9%) | 44 (64.7%) | 47 (69.1%) | |
Tumor invasion depth | Â | Â | Â | 0.162 |
 T1-T2 | 81 (59.6%) | 45 (66.2%) | 36 (52.9%) | |
 T3-T4 | 55 (40.4%) | 23((33.8%) | 32 (47.1%) | |
Lymph node metastasis | Â | Â | Â | 0.018 |
 N0 | 46 (33.8%) | 30 (44.1%) | 16 (23.5%) | |
 N1 + N2 | 90((66.2%) | 38 (55.9%) | 52 (76.5%) | |
Distant metastasis | Â | Â | Â | 0.002 |
 M0 | 117 (86.0%) | 65 (95.6%) | 52 (76.5%) | |
 M1 | 19 (14.0%) | 3((4.4%) | 16 (23.5%) | |
TNM stage | Â | Â | Â | 0.005 |
 I-II | 83 (61.0%) | 50 (73.5%) | 33 (48.5%) | |
 III-IV | 53 (39.0%) | 18 (26.5%) | 35 (51.5%) | |